@article{3fe6b388011e4c6cb602a6cea47f5594,
title = "Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China",
keywords = "Chinese population, Omalizumab, Real-world study, Severe asthma, Steroid-sparing effect, Humans, Middle Aged, Hypersensitivity/complications, Male, Treatment Outcome, Disease Progression, Asthma/diagnosis, Omalizumab/adverse effects, Patient Acuity, Young Adult, China, Adolescent, Adult, Female, Retrospective Studies, Respiratory Function Tests, Safety, Child, Glucocorticoids/administration \& dosage",
author = "Min Zhang and Meiling Jin and Xin Zhou and Jiangtao Lin and Xiansheng Liu and Chuntao Liu and Mao Huang and Wen Wang and Liang Chen and Yijiang Huang and Jing Li and Qingling Zhang and Huahao Shen and Yali Yu and Wei Tang and Jianying Zhou and Hongju Liu and Liang Dong and Yan Hu and Hua Wu and Yanhong Li and Weidong Song and Ming Ouyang and Xiaoling Yuan and Tao Wang and Shengdao Xiong",
note = "Copyright {\textcopyright} 2021 Elsevier Ltd. All rights reserved.",
year = "2021",
month = sep,
doi = "10.1016/j.rmed.2021.106522",
language = "English",
volume = "186",
journal = "Respiratory Medicine",
issn = "0954-6111",
}